These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [The problem of post-transfusion hepatitis]. Sugg M Beitr Infusionther Klin Ernahr; 1986; 15():30-8. PubMed ID: 3019299 [No Abstract] [Full Text] [Related]
8. [Rational microanalysis technic in the detection of antibodies to HTLV-III, CMV and EBV with indirect immunofluorescence]. Stöcker W; Geusendam G; Schmitz H; Mohr H; Berndt H Beitr Infusionther Klin Ernahr; 1986; 15():51-7. PubMed ID: 3019301 [No Abstract] [Full Text] [Related]
9. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion]. Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054 [No Abstract] [Full Text] [Related]
10. Current issues in blood component therapy: transmission of infectious diseases. Menitove JE Oncology (Williston Park); 1987 Jun; 1(4):21-30. PubMed ID: 2856350 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of viral hepatitis: transfusion transmitted disease and the hepatitis B vaccine. Holland PV Prog Clin Biol Res; 1983; 143():357-67. PubMed ID: 6322200 [No Abstract] [Full Text] [Related]
12. Transfusion-associated hepatitis and AIDS. What is the risk? Bove JR N Engl J Med; 1987 Jul; 317(4):242-5. PubMed ID: 3110619 [TBL] [Abstract][Full Text] [Related]
13. [Clinical aspects and risk factors in posttransfusion hepatitis]. Realdi G; Tremolada F; Chiappetta F; Antona C; Noventa F; Loreggian M; Chemello L; Alberti A Ric Clin Lab; 1984; 14 Suppl 1():17-35. PubMed ID: 6330858 [No Abstract] [Full Text] [Related]